Advertisement

Topics

Latest "Locus Discovery Incorporated" News Stories

02:16 EDT 21st July 2018 | BioPortfolio

Here are the most relevant search results for "Locus Discovery Incorporated" found in our extensive news archives from over 250 global news sources.

More Information about Locus Discovery Incorporated on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Locus Discovery Incorporated for you to read. Along with our medical data and news we also list Locus Discovery Incorporated Clinical Trials, which are updated daily. BioPortfolio also has a large database of Locus Discovery Incorporated Companies for you to search.

Showing "Locus Discovery Incorporated" News Articles 1–25 of 3,800+

Friday 20th July 2018

Global Aptamers Market Segmented by Type of Products and Applications Growth, Trends and Forecasts 2018 2023 [Report Updated: 08022018] Prices from USD $4250

The global Aptamers market has been estimated to reach USD 401.30 billion in 2023. The market is expected to register a CAGR of 17.89% during the forecast period 2018 to 2023. North America dominates the market due to the increasing technological advancements. Advancements in the field of aptamer development technologiesAdvancements in aptamer development technologies, increasing RD, and rising nu...


Koutif Therapeutics Confirms Clinical Candidate Drug

Company Expects to File IND Application in Late 2018 Koutif Therapeutics today announced that KT-1002, which has been selected as its lead compound, has reached clinical candidate status for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn’s Disease, after successfully completing IND-enabling studies. The biotech st...

AMSBIO Launch New Screening Company

ScreenIn3D (Glasgow, UK) is a new joint venture company set up by AMSBIO and the University of Strathclyde exploiting the latest advances in microfluidics and 3D culture to develop a novel microfluidic screening platform. he unique combination of microfluidic lab-on-a-chip technology with physiologically relevant 3D spheroids is designed to make drug discovery more closely relevant with what happe...


Sage Bionetworks Launches the Agora Platform Making Curated Genomic Analysis of Alzheimer’s Disease Widely Available

Researchers to access list of novel targets for Alzheimer’s disease treatment Sage Bionetworks announces the launch of the Agora platform (agora.ampadportal.org) an interactive, web-based tool that allows researchers to explore curated genomic analyses of Alzheimer’s Disease (AD), including a list of early candidate target nominations for AD...

Infrared Sensor As New Method For Drug Discovery

NewsUsing an infrared sensor, biophysicists at Ruhr-Universität Bochum (RUB) have succeeded in analyzing quickly and easily which active agents affect the structure of proteins and how long that effect lasts.

A DNA 'shield' with crucial roles in normal cell division

In immune cells, this is crucial to make antibodies In cancer, mutations in complex could lead to resistance to BRCA-targeting PARP inhibitor drugs or platinum chemotherapies Scientists have made a major discovery about how cells repair broken strands of DNA that could have huge implications for the...

New vaccine could protect unborn babies from Zika virus

Until recently, the Zika virus was not a priority since it affected relatively few people and the cost of creating a vaccine was estimated at EUR 149-468 million. But the spread of Zika in the Americas and discovery of a link with reduced head size and brain damage in babies of women infected while pregnant changed that.

Thursday 19th July 2018

New discovery could save millions of lives from fatal fungal infections

Life-threatening fungal infections affect more than two million people worldwide. Effective antifungal medications are very limited.

Global Industrial Starches Market Growth, Trends and Forecasts 2018 2023 [Report Updated: 01032018] Prices from USD $1923

The global industrial starch market size was estimated to be USD 103.5 billion in 2023 and is anticipated to witness a CAGR of 3.5% from 2018 to 2023 forecast period. The global industrial starches market has high potential for growth due to the multiple functionalities of starch, starch derivatives sweeteners in a diverse range of enduser industries.Market DynamicsThe extensive range of applicat...

Global Food Grade Glycerin Market Growth, Trends and Forecasts 2018 2023 [Report Updated: 01032018] Prices from USD $4250

The global food grade glycerin market size was estimated to be USD 3.1 billion in 2017 and is anticipated to grow at a CAGR of 6.2% from 2017 to 2023 forecast period. Food grade glycerin has high applications in various consumer products due to it's functionally and nutritive benefits. In the food and beverage industry it has applications such as food preservatives, sweeteners and also as a humect...

A molecular key for delaying the progression of Multiple Sclerosis is found

(University of the Basque Country ) In the lab it was possible to improve the symptoms in the chronic phase of the disease while encouraging the repair of the nervous tissue, and the challenge now is to move the research forward in humans. This discovery is the outcome of the work by an international consortium led in the Basque Autonomous Community by the UPV/EHU and the Achucarro centre together...

New findings on intercellular communication

(Université libre de Bruxelles) This is a nice example of a rather unexpected discovery: by studying the development of the blood vessels of the brain, researchers at Université libre de Bruxelles have just shed light on a question that was pending for 10 years! They provide a molecular mechanism conferring ligand specificity to Wnt signaling, an ancestral communication pathway present in all ve...

Kite and Gadeta Collaborate to Advance Gamma Delta T Cell Receptor Technology for Solid Tumors

SANTA MONICA, Calif. & UTRECHT, Netherlands–(BUSINESS WIRE)–Kite, a Gilead Company (Nasdaq: GILD), and Gadeta B.V., a privately-held company focused on the discovery and development of novel cancer immunotherapies based on gamma delta T cell receptors (TCRs), have entered into a strategic collaboration to develop novel gamma delta TCR therapies in various cancers. Under the financi...

Enzyme Identified as Possible Novel Drug Target for Sickle Cell Disease

NewsCHOP, Penn Researchers: CRISPR screening reveals signaling protein with key role in regulating hemoglobin in red blood cells.

Novel Protein Inhibitors Could Enhance Immunotherapy Response in Patients with Cancer

ArticleStudies to date have shown encouraging data for these drugs as potential combination therapies in indications such as metastatic pancreatic cancer, advanced bladder cancer and triple negative bladder cancer. Drug Discovery and Development spoke with Peter D. Suzdak, PhD, CEO of Rexahn Pharmaceuticals, whose company is on the forefront of some of these efforts, about the motivations and hope...

Global Radiology Information Systems Market Segmented by Type, Deployment mode, Component, EndUsers and Geography Growth, Trends and Forecasts 2018 2023 [Report Updated: 01032018] Prices from USD $4250

A radiology information system is a computer system that provides business analysis and effective workflow in the radiology department. The system helps in managing all the business functions of the department, from patient management and analysis, to inventory control. These systems are easy to use and are easily accessible. They offer benefits, such as high security, reliability, and privacy, an...

Grant announcement of Canadian patent by Oxford BioDynamics

The now patented technology platform, EpiSwitch, enables the high resolution discovery and monitoring of regulatory conditional chromosome conformation signatures

CrownBio Supports Excellence in Translational Research with Grant Award that Funds Innovative PDX Model Development in Immuno-Oncology

"Cancer Research Center of Lyon iPS novel PDX models formulate new immune cell focused strategies" SAN DIEGO, July  19, 2018  (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, is proud to announce the award of it...

Invicro Scientists Awarded Alavi-Mandell Publication Award and Named Finalist for the Ziskind-Somerfeld Research Award

Invicro LLC, a Konica Minolta company and a leading provider of imaging services and software for research and drug development, announces that a study conducted at Invicro London (formerly Imanova) has been awarded the Alavi-Mandell Publication Award by the Journal of Nuclear Medicine (JNM) for the publication entitled, “11C-PBR28 or 18F-PBR111 detect w...

Astronomers find 12 new moons, one oddball, orbiting Jupiter

Scientists announced the discovery of 12 new moons orbiting the planet Jupiter, including one that bucks the trend by orbiting in the opposite direction

Asana BioSciences Initiates Phase 2b Study of ASN002 in Patients with Moderate-to-Severe Atopic Dermatitis (RADIANT)

Asana BioSciences, a clinical stage biopharmaceutical company focused on discovery and development of novel targeted investigational medicines in Immunology/Inflammation and Oncology, today announced initiation of a Phase 2b study of ASN002, an oral JAK/SYK inhibitor, in patients with moderate-to-severe atopic dermatitis (AD). “I was impressed b...

BioAscent Secures Investment to Expand its Integrated Drug Discovery Services

BioAscent Discovery Limited has secured £1.6m in funding from Maven Capital Partners. The investment will facilitate BioAscent’s growth through its unique offering of integrated drug discovery, and compound management services, as well as the Compound Cloud library of lead-like pharma compounds, from its state-of-the-art facilityat BioCity...

Scientists discover protein regulator of myelin production

Scientists have made an important discovery about the role of a protein called PRMT5 in the production of myelin.

Pharmaceutical Regulatory Affairs in Africa (London, United Kingdom - October 1st-2nd, 2018) - ...

ResearchAndMarkets.comLaura Wood, Senior Managerpress@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900Related Topics: Drug Discovery Read more...

Kite collaborates with Gadeta to develop novel gamma delta TCR therapies for various cancers

Kite, a Gilead Company, and Gadeta B.V., a privately-held company focused on the discovery and development of novel cancer immunotherapies based on gamma delta T cell receptors, have entered into a strategic collaboration to develop novel gamma delta TCR therapies in various cancers.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks